É. Thervet

2.3k citations

47 papers · 1.5k indexed · h-index 22

Impact in

Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments
Nephrology top 5%
- Renal Diseases and Glomerulopathies

Papers in

Transplantation 27
- Renal Transplantation Outcomes and Treatments 27
Nephrology 5
- Renal Diseases and Glomerulopathies 5

Co-authors: Christophe Legendre Dany Anglicheau Lionel Rostaing Julien Zuber Antoine Thierry Dominique Nochy Georges Mourad D. Durand
Journals: Transplantation (10 papers)American Journal of Transplantation (7 papers)Nephrology Dialysis Transplantation (3 papers)Transplant International (2 papers)Clinical Kidney Journal (1 paper)
Partner nations: France United States United Kingdom

In The Last Decade

É. Thervet

44 papers receiving 1.4k citations

Peers

Countries citing papers authored by É. Thervet

Since Specialization

Citations

This map shows the geographic impact of É. Thervet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Thervet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Thervet more than expected).

Fields of papers citing papers by É. Thervet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Thervet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Thervet. The network helps show where É. Thervet may publish in the future.

Co-authors

The 25 scholars most cited alongside É. Thervet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with É. Thervet Line = papers co-authored together É. Thervet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study Transplant International ·Dominique Bertrand, Nathalie Chavarot, Jérôme Olagne, Clarisse Grèze, Philippe Gatault, Vidar Fykse, Charlotte Colosio, Maïté Jaureguy, Agnès Duveau, Nicolas Bouvier, Yannick Le Meur, Léonard Golbin, É. Thervet, Antoine Thierry, Arnaud François, Charlotte Laurent, Mathilde Lemoine, Dany Anglicheau, Dominique Guerrot	2024	4
2	Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease Clinical Kidney Journal ·Claire Trivin, Antoine Tran, Bruno Moulin, Gabriel Choukroun, Philippe Gatault, Cécile Courivaud, Jean‐François Augusto, Maxence Ficheux, Cécile Vigneau, É. Thervet, Alexandre Karras	2016	39
3	Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant Transplantation ·Élisabeth Cassuto, Georges‐Philippe Pageaux, Diego Cantarovich, Lionel Rostaing, Alexandre Loupy, Shuhang Huang, Christophe Duvoux, Karine Moreau, É. Thervet, Hakim Mazouz, 松並宏昌, Sébastien Dharancy, M. Kessler	2016	27
4	Rapport protéinurie/créatininurie : quelle place dans le diagnostic de la pré-éclampsie ? Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément ·Zhu Wei, V Mittal, Julien Taı̈eb, É. Thervet, Alexandra Benachi	2015	0
5	Aspects éthiques de la transplantation rénale (donneurs et receveurs) Néphrologie & Thérapeutique ·Marie‐France Mamzer, M. Ya. Tavadrus, Henri Kreis, É. Thervet, Frank Martinez, Renaud Snanoudj, Christian Hervé, Christophe Legendre	2012	2
6	Traitements immunosuppresseurs : mécanismes d’action et utilisation clinique Néphrologie & Thérapeutique ·É. Thervet, Julien Zuber, Rebecca Sberro, Guillaume Canaud, Dany Anglicheau, Renaud Snanoudj, Marie‐France Mamzer, Franck Martinez, Christophe Legendre	2011	4
7	Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four-Year Results of the Postconcept Study American Journal of Transplantation ·Yvon Lebranchu, Antoine Thierry, É. Thervet, M. Büchler, Isabelle Étienne, P.F. Westeel, Bruno Hurault de Ligny, Bruno Moulin, Feng Jiajia, T. Frouget, S. Girardot-Seguin, Olivier Toupance	2011	78
8	Long-term Impact of Subclinical Inflammation Diagnosed by Protocol Biopsy One Year After Renal Transplantation American Journal of Transplantation ·Antoine Thierry, É. Thervet, Vincent Vuiblet, J.M. Goujon, M.C. Machet, Laure‐Hélène Noël, Alberto Maria Colasante, F. Comoz, C. Cordonnier, Abel François, Louis Marcellin, S. Girardot-Seguin, Guy Touchard	2011	50
9	Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies American Journal of Transplantation ·Rébecca Sberro‐Soussan, Julien Zuber, Caroline Suberbielle‐Boissel, Sophie Candon, F. Martinez, Renaud Snanoudj, Marion Rabant, Nicolas Pallet, Dominique Nochy, Dany Anglicheau, Marianne Leruez, Alexandre Loupy, É. Thervet, Olivier Hermine, Christophe Legendre	2010	85
10	Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus American Journal of Transplantation ·Aude Servais, Frank Hayes, Olivier Toupance, Yvon Lebranchu, Antoine Thierry, Bruno Moulin, Isabelle Étienne, Claire Presne, Martina Casamenti, P. Le Pogamp, Yannick Le Meur, Denis Glotz, Gopi Krishna Ragulakollu, F Innocenti, É. Thervet	2009	58
11	Purpura rhumatoïde Néphrologie & Thérapeutique ·Évangéline Pillebout, Dominique Nochy, É. Thervet	2009	13
12	Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation Clinical Transplantation ·F Cantarovich, Frank Martinez, 北原孝宏, É. Thervet, Marie‐France Mamzer, Claudio González, Christophe Legendre	2009	13
13	Apports récents de la pharmacologie des traitements immunosuppresseurs utilisés en transplantation d’organe médecine/sciences ·É. Thervet	2008	1
14	Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study Toxicology and Applied Pharmacology ·Nicolas Pallet, Marion Rabant, Yi-Chun Xu-Dubois, Simone Kraus, 理会冨田, Sandrine Imbeaud, Nicolas Agier, Alexandre Hertig, É. Thervet, Christophe Legendre	2008	42
15	Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids American Journal of Transplantation ·M. Büchler, Sophie Caillard, S. Barbier, É. Thervet, Olivier Toupance, Hakim Mazouz, Bruno Hurault de Ligny, Yannick Le Meur, Antoine Thierry, F. Villemain, A.‐E. Heng, Bruno Moulin, Marie-Pascale Morin, C. Noël, Yvon Lebranchu	2007	148
16	Nouveaux outils en transplantation rénale Néphrologie & Thérapeutique ·É. Thervet, Christophe Legendre	2006	2
17	Comparison of Sequential Protocol using Basiliximab versus Antithymocyte Globulin with High-Dose Mycophenolate Mofetil in Recipients of a Kidney Graft from an Expanded-Criteria Donor Transplantation ·Nicolas Pallet, Dany Anglicheau, Frank Martinez, Marie‐France Mamzer, Christophe Legendre, É. Thervet	2006	11
18	Use of Neoral C2 monitoring: a European consensus Transplant International ·Björn Nashan, Andreas Böck, Jean‐Louis Bosmans, Klemens Budde, Johan W. de Fijter, Bryon Jaques, A. E. Johnston, R Lück, Karsten Midtvedt, Luis Pallardó, Andrew Ready, Ephrem Salamé, Mauro Salizzoni, Francisco Suárez, É. Thervet	2005	50
19	Sequential Protocols using Basiliximab versus Anti-Thymocyte Globulins in Renal-Transplant Patients Receiving Mycophenolate Mofetil and Steroids Transplantation ·Georges Mourad, Lionel Rostaing, Christophe Legendre, 黄天聚, É. Thervet, D. Durand	2004	149
20	Is there a place for isolated renal transplantation in the treatment of primary hyperoxaluria type 1? Experience from Paris Nephrology Dialysis Transplantation ·É. Thervet, C. Legendre, Michel Daudon, Yves Chrétien, Arnaud Méjean, Paul Jungers, Marie‐France Mamzer, Dominique Chauveau, Henri Kreis	1995	9

About É. Thervet

É. Thervet is a scholar working on Transplantation, Nephrology, Family Practice, Psychiatry and Mental health and Hepatology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (27 papers), Organ Transplantation Techniques and Outcomes (9 papers), Neurological Complications and Syndromes (6 papers), Organ Donation and Transplantation (5 papers), Renal Diseases and Glomerulopathies (5 papers), Renal and Vascular Pathologies (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and Pregnancy and Medication Impact (4 papers). The work is most often cited by research in Transplantation (812 citations), Nephrology (199 citations), Hepatology (187 citations), Psychiatry and Mental health (199 citations) and Epidemiology (386 citations). É. Thervet has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Christophe Legendre, Dany Anglicheau, Lionel Rostaing, Julien Zuber, Antoine Thierry, Dominique Nochy, Georges Mourad, D. Durand, Bruno Moulin and C. Legendre. Their work appears in journals such as Transplantation, American Journal of Transplantation, Nephrology Dialysis Transplantation, Transplant International and Clinical Kidney Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact